All Stories

  1. Uncertainty and agency in COVID-19 hotel quarantine in Australia
  2. Experiences of risk in Australian hotel quarantine: a qualitative study
  3. Effectiveness evaluation of digital contact tracing for COVID-19 in New South Wales, Australia
  4. What does PrEP mean for ‘safe sex’ norms? A qualitative study
  5. Trans and gender diverse people’s experiences of healthcare access in Australia: A qualitative study in people with complex needs
  6. Medical advocacy in the face of Australian immigration practices: A study of medical professionals defending the health rights of detained refugees and asylum seekers
  7. ‘If you can’t make it, you’re not tough enough to do medicine’: a qualitative study of Sydney-based medical students’ experiences of bullying and harassment in clinical settings
  8. Attitudes and Perceived Social Norms toward Drug Use among Gay and Bisexual Men in Australia
  9. The binding practices of transgender and gender-diverse adults in Sydney, Australia
  10. Research priorities during infectious disease emergencies in West Africa
  11. Communitarian societies and public engagement in public health
  12. National leadership needed on HIV Pre-exposure Prophylaxis (PrEP) access in Australia
  13. Ebola “Ring” Vaccine Trial Was Ethically Innovative
  14. Communities need to be equal partners in determining whether research is acceptable
  15. “Reasonable Availability” Criterion Remains Salient
  16. Critical role of ethics in clinical management and public health response to the West Africa Ebola epidemic
  17. The Health Care Consequences Of Australian Immigration Policies
  18. Ebola vaccine development plan: ethics, concerns and proposed measures
  19. Ebola: what it teaches us about medical ethics. A response to Angus Dawson
  20. Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence – a narrative review
  21. Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?
  22. HIV transmission law in the age of treatment-as-prevention
  23. S15.4 The unmet need and potential application of mpts for rectal use: implications for women and msm at risk of stis and hiv
  24. Prioritization of healthcare workers for experimental Ebola therapeutic would exacerbate existing inequalities
  25. Stakeholders’ engagement with Ebola therapy research in resource limited settings
  26. Ethical Testing of Experimental Ebola Treatments
  27. Considering Pre-Exposure Prophylaxis: Do the Pros Outweigh the Cons as an HIV Prevention Strategy?
  28. Compassionate use of experimental drugs in the Ebola outbreak
  29. Priorities for Ebola virus disease response in west Africa
  30. Ethical challenges for doctors working in immigration detention
  31. It’s Time: The Case for PrEP as an Active Comparator in HIV Biomedical Prevention Trials
  32. Debating Ethics in HIV Research: Gaps between Policy and Practice in Nigeria
  33. Ethical Issues in Adolescents' Sexual and Reproductive Health Research in Nigeria
  34. Mind the gap: An empirical study of post-trial access in HIV biomedical prevention trials
  35. Standard of Prevention in the Real World: A Qualitative Study of Principal Investigators in HIV Biomedical Prevention Trials
  36. Ethical Considerations in Determining Standard of Prevention Packages for HIV Prevention Trials: Examining PrEP
  37. The seventh (and last?) International Microbicides Conference: from discovery to delivery
  38. Ethics of ARV Based Prevention: Treatment‐as‐Prevention and PrEP
  39. Ethics of medical care and clinical research: a qualitative study of principal investigators in biomedical HIV prevention research
  40. How Good Is “Good Enough”? The Case for Varying Standards of Evidence According to Need for New Interventions in HIV Prevention
  41. Treatment-as-Prevention Needs to Be Considered in the Just Allocation of HIV Drugs
  42. BECAUSE WE CAN: CLASHES OF PERSPECTIVE OVER RESEARCHER OBLIGATION IN THE FAILED PrEP TRIALS
  43. No Sex Please in Sexuality Research
  44. Back to Basics in Clinical Research Ethics
  45. National guidelines for post-exposure prophylaxis after non-occupational exposure to HIV